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Introduction

Design Objectives

At $3.07 billion in 2013, the 3D printing industry was
projected to reach $12.8 billion in 2018 and exceed $21
billion by 2020 [1]. A lucrative part of this expanding
industry includes printing biocompatible medical
implants, devices and tissue scaffolds. A common
problem encountered with traditional devices and
implants, is that they are not unique to the patient,
making the surgeries more difficult and less effective.
Tissue scaffolds could also benefit from increased
strength and biocompatibility. To answer these
demands, customizable devices are being produced
from patient medical scans and CAD designs using 3D
printers. Traditionally, plastics such as poly (lactic acid)
(PLA) or poly (lactic-co-glycolic) acid (PLGA) are used in
3D printers because of their thermoplastic properties,
which make them easy to print. These plastics are
typically regarded as biocompatible but can degrade to
less biocompatible forms in the body and leave the
implant site, causing inflammatory and foreign body
responses. Because of these problems, there has been a
focus on developing new biomaterials for making
customizable and highly biocompatible, resorbable
implants.
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Applications

2.
3.

Discussion

Results

Produce a defined structure from spider silk protein
using a 3D printer.
Maintain inherent biocompatibility of synthetic
spider silk proteins.
Achieve comparable mechanical properties to
similar implants used in medicine.

3D Printer Design

Table 1. Final Results
Characteristic
Printer Design
Total Cost
*Cost of Commercial Lab 3D Printer
Aspect Ratio
Number of Spider Silk Protein Resins

Medical
Implants

$635
$100-150 K
4.8
2

Biocompatibility
It was found that all resins inhibited cell growth with
the lowest inhibition being 29.3% when compared to
the controls (see Table 1). However, favorable cell
attachment was shown (see Figure 1d).

AlamarBlue™ Assay: Cell Growth Inhibition †
12% rMaSp1 Cross-linked
6% rMaSp1:rMaSp2 IPA Post-treated
6% rMaSp1:rMaSp2

Methods

29.3%
72.9%
42.2%

Mechanical Data
Modified
3D Printer

Spider
Silk
Protein
Resin

System
Design

Maximum Stress – Compression
Energy to Break
Elastic Modulus
*Elastic Modulus 3D Printed B. Mori Silk
Maximum Strain
Maximum Stress – Shear
*PLGA – Shear
Data are presented as mean + standard deviation
*Values from literature
†Values are percentages with respect to the controls

65.1 + 12.2 kPa
10.7 + 2.3 kPa
555.8 + 215.1 kPa
~0.2 kPa
0.247 + 0.037 kPa
522 + 403 kPa
~100 MPa

Two spider silk protein resins were developed from
rMaSp1 and rMaSp1 recombinant spider silk proteins
derived from goats. The first was 6% by weight in
a 50:50 ratio and the second was a 12% rMaSp1 only.
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The modified Printrbot Simple Metal, as shown in
Figure 1a, uses Cura software. The printer was modified
with a 3D printed syringe pump utilizing a 5 ml syringe
and a 0.7 mm diameter needle (see Figure 1b).

A 3D printer system comprised of a synthetic spider silk
resin and a modified 3D printer was developed. A fused
filament 3D printer, purchased for under $550, was
modified with a custom syringe pump design. This
syringe pump allowed for the extrusion of spider silk
proteins through a needle, producing defined
structures. Cell studies were performed on these
structures which showed favorable cell attachment and
growth. As an alternative 3D printed biomaterial, spider
silk is capable of entering various emerging industries.

Mechanical Testing
Simple structures were post-treated by soaking in
either IPA, IPA & Cross-linking Solution (XLS), or XLS
only for 24 hours. These were tested in shear and to the
bio-yield point in compression on a 50 N load cell.

The printed spider silk had a greater Elastic Modulus
than those reported in literature for 3D printed B. mori
silk. However, the spider silk had significantly lower
shear values than those reported for PLGA (see Table 1).

Therefore the project was successful in designing an
inexpensive 3D printing system comprised of a spider
silk protein resin and modified FDM 3D printer that
produced defined spider silk structures. An aspect ratio
of 4.8, 29.3% cell inhibition, and compressive stress of
65.1+ 12.2 kPa were achieved. The system provides a
reliable platform on which to continue research.

Future Work

Biocompatibility Test
This was performed using an alamarBlue™ assay. Thin
resin films in 6 well plates were seeded with 300,000
goat fetal fibroblasts per well. 200ul of alamarBlue™
was added to each well and allowed to permeate the
cells for 6 hours before absorbance readings were taken
at 570 nm and 600 nm in a UV/VIS spectrophotometer.

Mechanical Data

Conclusion

Resin Formulation

Printer Setup

Tissue
Engineering

The total cost of the designed 3D printer was
significantly less than commercially available aqueous
3D printers (see Table 1). The silk was also able to be
printed at an aspect ratio of 4.8 (see Table 1, Figure 1e)

C

D

With the printing system in place, further studies will be
conducted to test the silk’s ability to perform as a
medical implant material and tissue scaffold. Additional
medical scans of increasing complexity will also be
printed to test the applicable resolution of the printer,
similar to the hyoid bone print seen in Figure 1f-g.

References
E

F

G

Figure 1. A) Completed system with modified syringe pump attached to
Printrbot Simple Metal 3D printer, B) CAD rendering of syringe pump
mechanism, C) Printed 5mm x 8mm spider silk cylinder used in
mechanical testing (4mm scale bar), D) Goat fetal fibroblast cells
showing favorable growth on cured spider silk resin, E) 3D printed spider
silk showing aspect ratio, F) Scanned model of human hyoid bone (NIH
3D Print Exchange), G) 3D printed spider silk hyoid bone dyed blue and
scaled down by ¼ (7mm scale bar).
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